{"entity":{"id":"nct05032040","kind":"trial","name":"A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies","aka":[],"tldr":"A phase 2 trial of vudalimab in ovarian cancer, endometrial cancer, cervical cancer and prostate cancer, run by Xencor, Inc., active and no longer recruiting.","summary":"A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies is a phase 2 interventional study registered as NCT05032040 by Xencor, Inc., with 170 participants enrolled, started 2022-07-21 and due to reach its primary completion in 2025-10-15. Interventions recorded: vudalimab.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05032040","url":"https://clinicaltrials.gov/study/NCT05032040"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["ovarian","endometrial","cervical","prostate","prostate-mcrpc"],"sections":[],"technologies":[],"targets":[],"drugs":["vudalimab"],"companies":["xencor","icon-plc"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05032040","phase":"2","setting":"A Phase 2 Study of XmAb20717 in Patients With Selected Gynecological Malignancies and Metastatic Castration-Resistant Prostate Cancer","sponsor":"Xencor, Inc.","started":"2022-07-21","startedType":"actual","enrolled":170,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05032040/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"prostate-mcrpc","kind":"cancer","name":"Metastatic castration-resistant prostate cancer","route":"/cancers/prostate-mcrpc/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"vudalimab","kind":"drug","name":"Vudalimab","route":"/drugs/vudalimab/"}],"company":[{"id":"icon-plc","kind":"company","name":"ICON plc","route":"/companies/icon-plc/"},{"id":"xencor","kind":"company","name":"Xencor","route":"/companies/xencor/"}]}}